Your browser doesn't support javascript.
loading
Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes.
Bennet, H; Balhuizen, A; Medina, A; Dekker Nitert, M; Ottosson Laakso, E; Essén, S; Spégel, P; Storm, P; Krus, U; Wierup, N; Fex, M.
Afiliação
  • Bennet H; Department of Clinical Science, Lund University Diabetes Centre, Scania University Hospital, Entrance 72, Clinical Research Centre House 91, Jan Waldenströmsgata 35, SE-20502, Malmö, Sweden.
  • Balhuizen A; Department of Clinical Science, Lund University Diabetes Centre, Scania University Hospital, Entrance 72, Clinical Research Centre House 91, Jan Waldenströmsgata 35, SE-20502, Malmö, Sweden.
  • Medina A; Department of Clinical Science, Lund University Diabetes Centre, Scania University Hospital, Entrance 72, Clinical Research Centre House 91, Jan Waldenströmsgata 35, SE-20502, Malmö, Sweden.
  • Dekker Nitert M; Department of Clinical Science, Lund University Diabetes Centre, Scania University Hospital, Entrance 72, Clinical Research Centre House 91, Jan Waldenströmsgata 35, SE-20502, Malmö, Sweden; Royal Brisbane Clinical School, UQ Centre for Clinical Research, The University of Queensland, Herston, QLD 4
  • Ottosson Laakso E; Department of Clinical Science, Lund University Diabetes Centre, Scania University Hospital, Entrance 72, Clinical Research Centre House 91, Jan Waldenströmsgata 35, SE-20502, Malmö, Sweden.
  • Essén S; The Centre for Analysis and Synthesis, Department of Chemistry, Lund University, Getingevägen 60, SE-22241, Lund, Sweden.
  • Spégel P; Department of Clinical Science, Lund University Diabetes Centre, Scania University Hospital, Entrance 72, Clinical Research Centre House 91, Jan Waldenströmsgata 35, SE-20502, Malmö, Sweden.
  • Storm P; Department of Clinical Science, Lund University Diabetes Centre, Scania University Hospital, Entrance 72, Clinical Research Centre House 91, Jan Waldenströmsgata 35, SE-20502, Malmö, Sweden.
  • Krus U; Department of Clinical Science, Lund University Diabetes Centre, Scania University Hospital, Entrance 72, Clinical Research Centre House 91, Jan Waldenströmsgata 35, SE-20502, Malmö, Sweden.
  • Wierup N; Department of Clinical Science, Lund University Diabetes Centre, Scania University Hospital, Entrance 72, Clinical Research Centre House 91, Jan Waldenströmsgata 35, SE-20502, Malmö, Sweden.
  • Fex M; Department of Clinical Science, Lund University Diabetes Centre, Scania University Hospital, Entrance 72, Clinical Research Centre House 91, Jan Waldenströmsgata 35, SE-20502, Malmö, Sweden. Electronic address: malin.fex@med.lu.se.
Peptides ; 71: 113-20, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26206285
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucagon / Ilhotas Pancreáticas / Receptor 5-HT1D de Serotonina / Receptor 5-HT2A de Serotonina / Diabetes Mellitus Tipo 2 / Insulina Limite: Female / Humans / Male Idioma: En Revista: Peptides Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucagon / Ilhotas Pancreáticas / Receptor 5-HT1D de Serotonina / Receptor 5-HT2A de Serotonina / Diabetes Mellitus Tipo 2 / Insulina Limite: Female / Humans / Male Idioma: En Revista: Peptides Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia